The therapeutic importance of insulin-like growth factor I (IGF-I) for the treatment of some central nervous system disorders, including premenstrual syndrome (PMS) and Rett syndrome in children is immense (Costales and Kolevzon, 2016). The gene discussed is IGF1; the disease is atypical Rett syndrome.